Course Details
- TOP
- Incentive Courses
-
Cancer Specialist Training Course: Personalized Genomic Medicine Through Molecular Pathology
| Name of University | Kanazawa Medical University | ||||||
|---|---|---|---|---|---|---|---|
| Course name | Cancer Specialist Training Course: Personalized Genomic Medicine Through Molecular Pathology(Incentive Courses) | ||||||
| Target Occupation | Clinical Doctors | ||||||
| Length of study (period) | 1 years (extension possible) | ||||||
| Human resources to be trained | We train oncologists who understand genome information, which is essential in the diagnosis and treatment of cancer, and also understand the results of pathological diagnosis and cancer gene panel tests, including those for children, AYA generation, and rare cancers, and can provide advice to medical professionals. | ||||||
| Cooperation with professional qualifications related to cancer | Accredited as a training facility for specialists in cancer pharmacotherapy (Japanese Society of Clinical Oncology), clinical geneticists (Japanese Society of Human Genetics, Japanese Society of Genetic Counseling), molecular pathologists (Japanese Society of Pathology), etc. | ||||||
| Characteristics of educational content | In light of the sophistication of the next generation of cancer treatment, it is essential to develop human resources capable of regional cooperation in cancer treatment. In particular, the training of cancer specialists who are well versed in genome medicine and who can understand pediatric, AYA, and rare cancers as well as hereditary tumors will enable seamless medical collaboration between base hospitals and regional medical centers. | ||||||
| Guidance system | It has several oncology pharmacotherapy specialists and molecular pathologists on staff, and as a collaborative facility for cancer genome medicine, it practices an expert panel based on cancer gene panel testing. In addition, as a facility specializing in clinical genetics, specialists familiar with familial tumors, genetic diagnosis, and genetic counseling will lecture on the skills necessary to provide multidisciplinary treatment for various types of cancer through e-learning or symposiums. | ||||||
| Career path of graduates | The physicians trained in this intensive course will contribute to cancer genome medicine at the regional collaborating core hospitals as the next generation of cancer treatment leaders who understand cancer genome information, can explain it to medical personnel, introduce and practice treatment, and promote collaboration in cancer team medicine consisting of multiple professions. | ||||||
| Number of students accepted | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | Total |
| 1 | 1 | 1 | 1 | 1 | 5 | ||
| Acceptance Goals | With the goal of assigning at least one oncologist practicing cancer genome medicine at each of the five cancer base hospitals in the prefecture, five oncologists will be trained over the next five years. In addition, since one applicant is expected each year based on the past number of applicants to the graduate school and the admission needs survey, the target number of accepted applicants is set at one. | ||||||
For graduate students from the six partner universities
Regular Graduate Course